4TVK | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A CHLOROTACRINE-JUGLONE HYBRID INHIBITOR | date | 2014-06-27 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Pesaresi, A., Samez, S., Lamba, D. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 | ||||||||||||
ligand | NAG, TJH | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-beta aggregation and to exert anticholinesterase and antioxidant effects., Nepovimova E, Uliassi E, Korabecny J, Pena-Altamira LE, Samez S, Pesaresi A, Garcia GE, Bartolini M, Andrisano V, Bergamini C, Fato R, Lamba D, Roberti M, Kuca K, Monti B, Bolognesi ML, J Med Chem. 2014 Sep 26. PMID:25259726 |
Data retrieval |
View 4TVK in 3D |
Visual 3D analysis of 4TVK |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4TVK |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |